Berenberg Bank Forecasts Strong Price Appreciation for Haleon (LON:HLN) Stock

Haleon (LON:HLN) had its price target boosted by stock analysts at Berenberg Bank from GBX 507 to GBX 517 in a research note issued to investors on Wednesday,Digital Look reports. The brokerage currently has a “buy” rating on the stock. Berenberg Bank’s price objective points to a potential upside of 44.90% from the company’s previous close.

A number of other brokerages have also recently issued reports on HLN. Jefferies Financial Group restated a “buy” rating and set a GBX 440 price objective on shares of Haleon in a report on Monday. JPMorgan Chase & Co. reaffirmed an “underweight” rating on shares of Haleon in a research note on Friday, October 31st. The Goldman Sachs Group reaffirmed a “buy” rating and issued a GBX 440 target price on shares of Haleon in a research report on Wednesday, September 10th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and issued a GBX 370 target price on shares of Haleon in a research note on Friday, October 31st. Three investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of GBX 441.75.

Haleon Trading Down 0.1%

LON HLN opened at GBX 356.80 on Wednesday. The company has a market cap of £31.78 billion, a PE ratio of 21.37, a PEG ratio of 1.49 and a beta of 0.19. The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 53.36. Haleon has a 12 month low of GBX 325.10 and a 12 month high of GBX 419.50. The stock has a 50 day moving average of GBX 347.45 and a 200-day moving average of GBX 369.11.

About Haleon

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s product portfolio spans six major categories – Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.